BVF »

Onkure Therapeutics Inc-a shares owned by BVF

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by BVF from 13F filings

Historical chart of BVF investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by BVF

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.2M 2.0M 4.14

More positions owned by BVF

Kymera Therapeutics (KYMR)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Revolution Medicines (RVMD)
Nektar Therapeutics Com New (NKTR)
Structure Therapeutics Sponsored Ads (GPCR)
Mirum Pharmaceuticals (MIRM)
Gh Research Ordinary Shares (GHRS)
Palvella Therapeutics Inc Ne (PVLA)
Zymeworks Del (ZYME)
Xencor (XNCR)
Stoke Therapeutics (STOK)
Cullinan Oncology (CGEM)
Disc Medicine (IRON)
Xoma Royalty Corporation Com New (XOMA)
Olema Pharmaceuticals (OLMA)

View all positions for BVF

Top funds holding Onkure Therapeutics Inc-a

RA Capital Management
Acorn Capital Advisors
StepStone
ADAR1 Capital Management
BVF
Vivo Capital
Vestal Point Capital
Foresite Capital Management VI
Prosight Management
Rosalind Advisors
Vanguard Group
Vanguard Capital Management
Highbridge Capital Management
NEA Management Company
Carlyle

View all funds holding Onkure Therapeutics Inc-a